Bausch + Lomb launches preservative-free dry eye drops in US Jun 1, 2026 06:59AM
Bausch + Lomb launches PreserVision AREDS3 eye vitamins in US May 19, 2026 07:01AM
Needham tracks April prescription trends for Alcon and Bausch + Lomb eye drugs May 8, 2026 09:55AM
Bausch + Lomb launches advanced vitrectomy cutter in Europe May 7, 2026 07:01AM
Bausch & Lomb Corp. (BLCO) PT Raised to $16 at BofA Securities Apr 30, 2026 04:35AM
View Older Stories

Apr 29, 2026 05:15PM Bausch & Lomb Corp. (BLCO) PT Lowered to $16 at Evercore ISI
Apr 29, 2026 07:02AM Bausch + Lomb Corporation (BLCO) Tops Q1 EPS by 3c, provides guidance
Apr 23, 2026 07:08AM Bausch + Lomb launches PreserVision AREDS3 vitamins with B complex
Apr 14, 2026 08:02AM Bausch Health launches Biafine skincare product online in US
Apr 7, 2026 07:26AM Bausch + Lomb launches enVista Envy intraocular lenses in Europe
Mar 23, 2026 07:01AM Bausch + Lomb reports positive 24-month trial data for glaucoma treatment
Mar 17, 2026 09:36AM RBC Capital on Bausch & Lomb Corp. (BLCO): 'We view the delay in anticipated competition in the US Rx DED market as neutral to slightly positive'
Feb 24, 2026 06:36AM Bausch & Lomb Corp. (BLCO) PT Raised to $20 at H.C. Wainwright
Feb 19, 2026 09:54AM Bausch & Lomb Corp. (BLCO) PT Raised to $16 at Stifel, Hold Rating Maintained
Feb 18, 2026 07:00AM Bausch + Lomb Corporation (BLCO) Misses Q4 EPS by 4c ; Offers Guidance
Feb 17, 2026 10:38AM Bausch & Lomb Corp. (BLCO) PT Raised to $15 at Stifel
Jan 27, 2026 04:29AM Bausch & Lomb Corp. (BLCO) PT Raised to $21 at RBC Capital
Jan 15, 2026 07:41AM Bausch & Lomb (BLCO) Reiterated at Hold by Stifel: Concerns About Execution
Jan 2, 2026 04:12PM Bausch + Lomb refinances $2.8 billion in debt with lower rates
Dec 17, 2025 04:30PM Bausch + Lomb adds two directors to board effective January 2026
Dec 12, 2025 04:50PM Bausch + Lomb plans $2.8 billion loan refinancing to cut interest rates
Nov 14, 2025 05:56AM Needham Reiterates Hold Rating on Bausch & Lomb Corp. (BLCO)
Nov 14, 2025 04:30AM Bausch & Lomb Corp. (BLCO) PT Raised to $19 at RBC Capital
Nov 14, 2025 04:25AM Bausch & Lomb Corp. (BLCO) PT Raised to $20 at Jefferies
Nov 13, 2025 07:01AM Bausch + Lomb sets three-year growth targets at investor day
Nov 5, 2025 04:38AM Needham Reiterates Hold Rating on Bausch & Lomb Corp. (BLCO)
Oct 29, 2025 06:59AM Bausch + Lomb Corporation (BLCO) Tops Q3 EPS by 2c
Oct 14, 2025 07:26AM Stifel Reiterates Hold Rating on Bausch & Lomb Corp. (BLCO); Says Cautious on New Market Execution
Oct 1, 2025 04:16AM Goldman Sachs Starts Bausch & Lomb Corp. (BLCO) at Neutral
Aug 4, 2025 05:07AM Bausch & Lomb Corp. (BLCO) PT Raised to $13 at BofA Securities
Aug 1, 2025 06:50AM Bausch & Lomb Corp. (BLCO) PT Raised to $16 at H.C. Wainwright
Jul 30, 2025 06:59AM Bausch + Lomb Corporation (BLCO) Tops Q2 EPS by 1c ; Offers Guidance
Jul 15, 2025 09:45AM RBC Capital on Bausch & Lomb Corp. (BLCO): 'FX Likely a Tailwind'
Jul 10, 2025 07:29AM Stifel Reiterates Hold Rating on Bausch & Lomb Corp. (BLCO)
Jun 18, 2025 04:32PM Bausch + Lomb Corporation (BLCO) Prices Upsized EUR 675M Notes Offering
Jun 10, 2025 08:48AM Bausch + Lomb Corporation (BLCO) Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement
Jun 6, 2025 10:52AM Bausch & Lomb Corp. (BLCO) PT Lowered to $16 at Barclays
Jun 4, 2025 06:59AM Bausch + Lomb Corporation (BLCO) Launches Blink Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the US
May 21, 2025 04:35PM Bausch + Lomb Corporation (BLCO) announces AGM voting results
May 14, 2025 06:59AM Bausch + Lomb Corporation (BLCO) Launches Zenlens CHROMA HOA in the U.S.
May 2, 2025 07:27AM Bausch & Lomb Corp. (BLCO) PT Lowered to $15 at H.C. Wainwright
Apr 30, 2025 07:02AM Bausch + Lomb Corporation (BLCO) Misses Q1 EPS by 9c; raises guidance
Apr 29, 2025 05:17AM Wells Fargo Reiterates Equal Weight Rating on Bausch & Lomb Corp. (BLCO)
Apr 24, 2025 07:00AM Bausch + Lomb Corporation (BLCO) Returning enVista Intraocular Lenses to Market Following Voluntary Recall
Apr 4, 2025 08:49AM Bausch & Lomb Corp. (BLCO) PT Lowered to $17 at RBC Capital on Revised Estimates
Apr 3, 2025 07:53AM Bausch & Lomb Corp. (BLCO) PT Lowered to $15 at Stifel
Mar 28, 2025 02:21AM Wells Fargo Downgrades Bausch & Lomb Corp. (BLCO) to Equal Weight
Feb 24, 2025 08:40AM Bausch & Lomb Corp. (BLCO) PT Lowered to $18 at Morgan Stanley
Feb 21, 2025 06:46AM Bausch & Lomb Corp. (BLCO) PT Lowered to $20 at H.C. Wainwright
Feb 20, 2025 05:16AM Bausch & Lomb Corp. (BLCO) PT Lowered to $17 at BofA Securities
Feb 19, 2025 03:00PM Bausch & Lomb Corp. (BLCO) PT Lowered to $17 at JPMorgan
Feb 19, 2025 06:59AM Bausch + Lomb Corporation (BLCO) Tops Q4 EPS by 1c; offers guidance
Feb 18, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Bausch & Lomb Corp. (BLCO)
Feb 6, 2025 07:05AM Bausch Health Provides Update on Strategic Alternatives
Feb 6, 2025 07:02AM Bausch + Lomb (BLCO) Provides Update on Potential Sale
View Older Stories